Back

Mid-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy in young patients.

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Implantable Cardioverter / Defibrillator Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2019

About the speaker

Photo
Mr Javier Ramos Maqueda

UNIVERSITY HOSPITAL CLINIC LOZANO BLESA, Zaragoza (Spain)

14 More presentations in this session

Presentation thumbnail
Implantable cardioverter defibrillator and resynchronisation therapy in patients with dilated cardiomyopathy:efficiency in prevention of sudden cardiac death
Presentation thumbnail
Time to therapy delivery and effectiveness of subcutaneous implantable cardioverter defibrillator.
Associate Professor I. Diemberger (Bologna, IT)
Abstract
Presentation thumbnail
Appropriate and inappropriate ICD therapy with evidence-based programming: a real-world comparison with trial data
Doctor M. Chapman (Middlesbrough, GB)
Abstract
Presentation thumbnail
Determinants of battery longevity of internal cardioverter defibrillators with and without cardiac resynchronization capabilities
Doctor R. Brenner (St. Gallen, CH)
Abstract Slides
Presentation thumbnail
Day case complex devices - The state of the UK
Doctor M. Waight (London, GB)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Implantable Cardioverter / Defibrillator

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources